Lung cancer
Conditions
Interventions
Arm A (standard surveillance): (i) physical examination and visual inspection every 6 months for 5 years after surgery, (ii) tumor marker (CEA) test every 6 monthe for 5 years after surgery, (iii) che
Sponsors
SHIONO Satoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Pathologically proven non small cell lung cancer (adenocarcinoma, squamous cell carcinoma, large cell nuroendcrine carcinoma or carcinoid tumours in neuroendocrine tumours, large cell carcinoma, adenosquamous carcinoma, sarcomatoid carcinoma other and unclassified carcinoma or salivary gland-type tumours) with resected specimen (2) Received segmentectomy, lobectomy, or pneumonectomy with mediastinal lymphadenectomy (3) Patholocial stage IIA, IIB or IIIA (4) Pathologically confirmed complete resection (R0) (including R0(un)) with resected specimen (5) Aged 20 years or older at the registration (6) ECOG Performance status is 0 or 1 (7) No complications after surgery which needs treatment (8) No recurrence defined as plain chest X-ray after surgery (9) Within 91 days after surgery (10) No prior and planed radiotherapy for the lung cancer after surgery (11) Written informed consent isobtained
Exclusion criteria
Exclusion criteria: 1) Synchronous or metachronous (within 5 years) malignancies 2) Severe psychological disease. 3) Routine thoracoabdominal and pelvic CT scan at least once a year due to past medical history / comorbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Relapse-free survival, Disease-free survival, Proportion of local reccurence, Proportion of clinical reccurence, Proportion of second malignancies, Number of CT examed, Number of each imaging test (except CT), Proportion of adverse events (adverse reactions), lung cancer-specific survival | — |
Contacts
Public ContactSatoshi SHIONO
Yamagata University Hospital
Outcome results
None listed